Emiac Technologies IPO Subscription Status
Emiac Technologies IPO subscription started on 27 March, 2026 and will close on 8 April, 2026. The retail quota is 33.70%, QIB is 46.67% and NII is 14.44%. Emiac Technologies IPO got a lot of interest, raising around ₹32,40,000 shares (agg. up to ₹32 Cr) Crores, with subscriptions [.] times overall, including [.] times by institutional investors, [.] times by non-institutional investors, and [.] times by retail investors. Shares are priced between ₹₹93 to ₹98 per share each and will be listed on the BSE.
Last Updated - [.]
|
Check Live IPO Subscription List 👈
|
| Upcoming |
Emiac Technologies IPO Subscription - Day [.]
| QIB - Qualified Institutional Buyers: | [.]x |
| NII - Non-Institutional Investors: | [.]x |
| SNII - Small Non-Institutional Investors: | [.]x |
| BNII - Big Non-Institutional Investors: | [.]x |
| RII - Retail Individual Investor: | [.]x |
| Total: | [.]x 👈 |
Emiac Technologies IPO Investor Categories
- Qualified Institutional Buyers: QIB
- Non-Institutional Investors: NII
- Small Non-Institutional Investors: SNII- Bid below ₹10L
- Big Non-Institutional Investors: BNII- Bid above ₹10L
- Retail Individual Investor: RII
- Employees Quota: EMP
Emiac Technologies IPO Dates
| IPO Activity | Date |
|---|---|
| Open Date: | 27 March, 2026 |
| Close Date: | 8 April, 2026 |
| Allotment Date: | 9 April, 2026 |
| Refund Date: | 10 April, 2026 |
| Shares Credit Date: | 10 April, 2026 |
| Listing Date: | 13 April, 2026 |
Emiac Technologies IPO Subscription Status FAQs
Q.When Emiac Technologies IPO Subscription will start?
Ans.The IPO subscription starts on 27 March, 2026 for Investors.
Q.What is the Emiac Technologies IPO Subscription last date?
Ans.Emiac Technologies IPO subscription last date is 8 April, 2026 for Investors.
Q.What is the Emiac Technologies IPO Allotment Date?
Ans.Emiac Technologies IPO allotment date is 9 April, 2026.
Q.What is the Emiac Technologies IPO Listing Date?
Ans.Emiac Technologies IPO listing date is 13 April, 2026. The IPO is to list on BSE.